Details of the Drug Reposition

General Information of This Drug (ID: DM0QZJX)

Drug Name
JNJ-55308942   DM0QZJX

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
3 Phase 1 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Neuroinflammation DIS1DQ79 1D0Y Phase 1 [1]
Mood disorder DISLVMWO 6A60-6E23 Phase 1 [2]
Anhedonia DISDO9FX MB24.2 Phase 1 [1]
------------------------------------------------------------------------------------

References

1 Antibodies and venom peptides: new modalities for ion channels. Nat Rev Drug Discov. 2019 May;18(5):339-357.
2 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)